Overall, more work is needed to characterize the impact that PD-1 blockade has on the NK cell population in the setting of these viral infections; however it is clear based on the CD8 T-cell response alone that PD-1 blockade is a promising therapeutic that deserves further examination in the setting of infectious diseases (249). The gene discussed is PDCD1; the disease is infectious disease.